Sappi’s never-ending quest to find new ways to extract value from trees has resulted in unique applications for our Valida line of products, ranging from Sappi’s own papermaking to foods and cosmetics, and even as…
The hygiene and health company Essity has once again been recognized for its leadership in sustainability by the global non-profit environmental organization CDP. The company is awarded a place on CDP’s prestigious A List for…
At Peloton we’re committed to fostering a sense of belonging for all of our Members and improving access to physical and mental well-being through our products, content, and community partnerships. To bring our commitment to…
Kepley Biosystems, a North Carolina biotechnology company, has been awarded a $1 million National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant to continue product development in sepsis diagnosis and management. The grant, entitled,…
The stress levels of Americans are rising rapidly according to the American Psychological Association (APA). The results of the Stress in America Survey 2022, reveal that the stress and decline of Americans’ mental health is due…
RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing, and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced promising six-month stability…
Despite busy lives and full schedules, finding time for regular meals with loved ones encourages connections and conversations that can benefit mental and physical well-being. Gathering your family, friends, coworkers or neighbors at least once…
(Family Features) Whether you’re celebrating a special occasion, saying “I love you” to a faraway relative or offering a kind gesture to a friend or neighbor, sending a gift is a thoughtful way to share…
Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit Interim data from Phase 1/2 glycogen storage disease 1a…
CAMBRIDGE, MA / ACCESSWIRE / September 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
